Discount Agreement for Vareniclin (ATC N07BA03)
DAK-Gesundheit is entering into non-exclusive discount agreements for Vareniclin (ATC N07BA03) to facilitate access for all interested pharmaceutical companies. The agreements are valid from 01.08.2026 to 31.07.2028 with an extension option.
CONTRACTING AUTHORITY
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33600000, Pharmaceutical products.
ADDITIONAL DETAILS
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
1083 days remaining(LOT-0001)
Published